Side-by-side financials for BNTC and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BNTC | NVS |
|---|---|---|
| Market cap | - | $282.64 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$37.92M | - |
| SEC filings | 309 | 947 |
Full pages: Benitec Biopharma Inc. and Novartis AG, or browse the full rankings.